Procalcitonin as Marker of Recurrent Medullary Thyroid Carcinoma: A Systematic Review and Meta-Analysis
Pierpaolo Trimboli (Trimboli P), Luca Giovanella (Giovanella L)
Endocrinol Metab. 2018;33(2):204-210.   Published online 2018 Jun 21     DOI:
Citations to this article as recorded by Crossref logo
A pregnancy-specific reference interval for procalcitonin
Samuel Dockree, Jennifer Brook, Tim James, Brian Shine, Manu Vatish
Clinica Chimica Acta.2021; 513: 13.     CrossRef
Clinical performance of calcitonin and procalcitonin Elecsys® immunoassays in patients with medullary thyroid carcinoma
Luca Giovanella, Martina Fontana, Franco Keller, Frederik A. Verburg, Luca Ceriani
Clinical Chemistry and Laboratory Medicine (CCLM).2021; 59(4): 743.     CrossRef
Correlation between preoperative ultrasonic features of medullary thyroid carcinoma and postoperative recurrence
Qiaodan Zhu, Dong Xu
BMC Cancer.2021;[Epub]     CrossRef
Calcitonin and complementary biomarkers in the diagnosis of hereditary medullary thyroid carcinoma in children and adolescents
Felix Eckelt, Roland Pfaeffle, Wieland Kiess, Juergen Kratzsch
Journal of Pediatric Endocrinology and Metabolism.2021;[Epub]     CrossRef
Medullary thyroid carcinoma: recent advances in identification, treatment, and prognosis
Marisa A. Bartz-Kurycki, Omowunmi E. Oluwo, Lilah F. Morris-Wiseman
Therapeutic Advances in Endocrinology and Metabolism.2021; 12: 204201882110496.     CrossRef
The Diagnostic and Antibiotic Reference Values of Procalcitonin for Intracranial Infection After Craniotomy
Lei Zhu, Lun Dong, Yuping Li, Guangyu Lu, Hengzhu Zhang, Xingdong Wang, Xiaoguang Liu, Zhenfei Teng, Boming Xia, Peng Zhang
World Neurosurgery.2019; 126: e1.     CrossRef
Triennial Report ofEndocrinology and Metabolism, 2015 to 2017
Eun-Jung Rhee, Hey Yeon Jang, Won-Young Lee
Endocrinology and Metabolism.2018; 33(2): 195.     CrossRef